Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas

Roswarski, Joseph; Roschewski, Mark; Melani, Christopher; Pittaluga, Stefania; Lucas, Andrea; Steinberg, Seth M.; Jaffe, Elaine S.; Waldmann, Thomas A.; Wilson, Wyndham H.

期刊名称Leukemia & Lymphoma
作者Roswarski, Joseph; Roschewski, Mark; Melani, Christopher; Pittaluga, Stefania; Lucas, Andrea; Steinberg, Seth M.; Jaffe, Elaine S.; Waldmann, Thomas A.; Wilson, Wyndham H.
印刷ISSN1042-8194
电子ISSN1029-2403
文件大小1039.06KB
发表时间2019-01-10
DOI10.1080/10428194.2018.1562184
页码1-5

发现好书期刊，享受阅读乐趣

Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas